Glepaglutide — ≥99% Research Peptide
Long-Acting GLP-2 Analog for Intestinal Adaptation Research
Zealand Pharma's long-acting GLP-2 receptor agonist developed for short-bowel-syndrome research — distinct from the GLP-1 class, with a focus on intestinal mucosal growth and absorption.
Research Applications & Benefits
- Long-acting GLP-2 receptor agonism
- Intestinal mucosal-adaptation research tool
- Twice-weekly subcutaneous dosing in research models
- Mechanism distinct from GLP-1 incretin class
Product Specifications
- Compound
- Glepaglutide
- CAS Number
- 1825266-87-4
- Molecular Weight
- ~4400 g/mol
- HPLC Purity
- ≥99% (independently verified by CertikLabs)
- Category
- GLP-1 & Metabolic
- Starting Price
- $169.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
Every Glepaglutide batch sold by PeptidesDirect is independently tested for purity (HPLC), identity (LC-MS), and concentration. A batch-specific Certificate of Analysis is available on request and anchored to a CertikLabs verification record for public inspection.
Frequently Asked Questions
Is Glepaglutide suitable for human consumption?
No. Glepaglutide is sold strictly for in-vitro laboratory research. It is not a drug, supplement, cosmetic, or food product and must not be administered to humans or animals.
What purity is Glepaglutide?
Glepaglutide ships at ≥99% verified by reverse-phase HPLC with mass-spec identity confirmation on every batch.
How is Glepaglutide shipped and stored?
Vials are shipped lyophilized in temperature-controlled packaging. Store unopened lyophilized peptide at −20°C; once reconstituted with bacteriostatic water, store at 2–8°C and use within 28 days.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
